Exam 3 - Poxviruses Flashcards

1
Q

poxvirus characteristics

A
  • large, linear dsDNA
  • enveloped
  • complex rectangular shape
  • poxviridae family
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

poxiruses cause ___________________

A

exanthematous disease - rash differs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

4 poxviruses that infect humans:

A
  • smallpox (variola)
    -monkeypox
  • molluscum contagiosum
  • vaccinia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

smallpox is caused by the _______ virus

A

variola

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

smallpox survivors are:

A

scarred by poxmarks and corneal blindness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

smallpox was carried by ______________ to ____________

A

explorers/traders; New World

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

smallpox was eradicated in ________

A

1980 (WHO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

mass smallpox vaccination of children is discontinued unless ________________

A

traveling outside of the US where smallpox is

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Variola minor virus

A
  • less common
  • milder disease
  • 1-2% mortality rate in unvaccinated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Variola major virus

A
  • more common
  • extensive rash, high fever
  • 30% mortality rate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

vaccine modified variola major

A

mild not lethal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

flat or malignant pox variola major

A

very severe, 96% mortality rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

hemorrhagic variola major

A

very severe, 96% mortality rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

smallpox transmission

A

person to person contact, fomites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

smallpox clinical features

A
  • skin rash –> crusts –> scabs fall off
  • 12-14 incubation period
  • prodromal period (2-4 days) - symptoms begin
  • vescicles rupture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

when is smallpox contagious

A

onset of rash to when all scabs come off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

monkeypox was isolated from ____________

A

cynomolgus monkeys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

history of monkeypox

A
  • disease of rainforest animals
  • adapted to be able to spread between humans
  • 2022 outbreak
19
Q

monkeypox clinical features

A
  • milder - like ordinary or vaccine modified smallpox
  • rash
  • 3-17 incubation period
  • 3-6% fatality rate
20
Q

monkeypox transmission

A

close person to person contact

21
Q

least concerning poxvirus

A

molluscum contagiosum (MCV)

22
Q

molluscum contagiosum (MCV) clinical features

A
  • pin, pearl-like lesions
  • centrifugal rash
  • 2-8 week incubation period
  • self-limiting (up to 5 years)
23
Q

molluscum contagiosum (MCV) transmission

A

direct contact or formites
- rapid in daycare centers and kindergarten

24
Q

vaccinia virus clinical features

A
  • localized skin infection
  • immunocompromised/pre-existing skin conditition - severe, systemic disease
25
vaccinia virus is used to vaccinate against _________ and protects against _________
smallpox; monkeypox
26
vaccinia virus is most similar to ______________
buffalopox
27
___________ is the model for all poxviruses
vaccinia virus
28
poxvirus virion
- M, mulberry (vesicular fluid) - C, capsule (dried scabs) - dumbbell-shaped core - lateral bodies - outer membrane
29
Lateral bodies
enzymes essential for viral replication
30
Vaccinia replication cycle
CYTOPLASM 1. Entry - cell surface GAGs - mature virion (MV) - 2 memb. (golgi & plasma memb.) - extracellular virion (EV) - 1 memb. (golgi) 2. Uncoating - core enters cytoplasm 3. DNA Replication - DNAP 4. Transcription - early genes - mRNA packaged into virion - intermediate - late genes - after genome replication 5. mRNA Turnover - D10 decapping enzyme 6. Maturation 7. Assembly - core memb., interactions with cytoskeleton 8. Release - MV (cell lysis), EV (membrane fusion, loses 1 membrane as released)
31
poxvirus immune evasion
- secretes viroreceptors and virokines - produce intracellular proteins to interfere with signaling
32
poxvirus antiviral - Tecovirimat
- treatment of smallpox - inhibits VP37 envelope wrapping protein
33
poxvirus antivirals - Brincidofovir and Cidofovir
- B = treatment of smallpox - C = treatment of CMV in AIDS patients - nucleoside/nucleotide analog
34
smallpox vaccination - variolation
puncturing of the skin with a smallpox scab from infected person to induve a localized reaction
35
smallpox vaccination - arm to arm passage
vesicle/postule fluid of a previously vaccinated person - not safe (spread of other diseases), banned
36
smallpox vaccination - US
cowpox lesions from infected calves - glycerin added to prevent contamination - emulsify and centrifuge to yield vaccine lymph
37
modern smallpox vaccination - Dryvax
- live, attenuated - 2 doses, bifurcated needle - cultured in skin of calves and freeze dried
38
modern smallox vaccination - ACAM2000
- propogate attenuated virus in cell culture - current vaccine used and in stockpile
39
smallpox vaccine is only given to:
vaccine lab workers, healthcare, military
40
Jynneos vaccine
- best current Smallpox vaccine, in stockpile - recommended for monkeypox - subcutaneous or intradermal injection (no scab formation)
41
smallpox eradicated
- no animal reservoirs - no long-term carrier state - highly effective, inexpensive freeze-dried vaccine - easy surveillance - centrifugal rash - containment vaccine - surveillance containment
42
goal of variola research
- develop antivirals - improve vaccines
43
why is there destruction of variola stocks
- concerns about bioterrorism and biowarfare - use of synthetic biology to build new virus